More about Torrent Pharmaceuticals Limited
Fundamentals for Torrent Pharmaceuticals Limited
Regulatory Filings for Torrent Pharmaceuticals Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Technicals for Torrent Pharmaceuticals Limited
Price Summary
On 2026-02-25, Torrent Pharmaceuticals Limited's stock opened at 4420.0, reached 4443.5, hit a low of 4358.0, and rose -0.02% to close at 4418.9, with 359909 shares traded.The stock reached its highest price of 4418.9 and lowest price of 2930.3 over the last 52 weeks.
Technicals
Aroon: Aroon's bullish trend persists, with Aroon Up holding steady at the 100 level. This shows strong momentum, but further exploration using additional indicators is necessary to confirm the trend's durability and potential future direction.
Bol. Bands: The current state of the BOLL BANDS is neutral, providing no clear signals for either an upward or downward movement. This indicates that the market may be in a state of equilibrium, with no strong momentum in either direction.
Parabolic SAR: The PSAR continues to be bullish for TORNTPHARM, setting a strong support level that could sustain the ongoing upward trend. This level of support indicates that the market is likely to continue its positive trajectory, offering a base for continued bullish movement.
Stochastic: The stochastic indicator shows bullish conditions, with the K-line positioned above the D-line and exceeding the 80 level. This setup suggests strong upward momentum, indicating that the market may continue to rise. Investors might view this as a favorable sign for continued growth.
Tripple Moving Agerage: The 20, 50, and 100 moving averages are aligned in a bearish formation, suggesting a downtrend. However, the slopes of the 20 and 50 SMAs are beginning to waver, indicating that the bearish momentum may be losing strength. This weakening could signal a potential shift towards bullish price action, as the market's current downward trajectory shows signs of faltering and a possible reversal may be near for TORNTPHARM.
Before focusing on technical indicators like stock price and volume, it's important to consider a company's fundamentals. These include financial metrics such as profitability, revenue growth, and debt levels. Furthermore, understanding the industry landscape, including competition and consumer trends, provides essential context. By combining this fundamental analysis with technical data, investors can make more informed decisions and draw deeper conclusions about the company's potential for future growth and success.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction